Aligos Therapeutics, Inc. ALGS
NASDAQ · United States · Health Technology
$5.54+0.04 (+0.73%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.14 | -1.09 | +87.2% | $27.78M | +12.6% | +17.9%$4.74→$5.59 |
| Q1 2026 | 2026-05-07 | -2.21 | -2.29 | +3.5% | — | — | +1.1%$6.37→$6.44 |
| Q4 2025 | 2026-03-05 | -1.91 | -2.49 | +23.3% | — | — | +1.7%$6.86→$6.98 |
| Q3 2025 | 2025-11-06 | -3.04 | -2.09 | -45.5% | — | — | -3.5%$7.33→$7.07 |
| Q4 2024 | 2025-03-10 | -13.10 | -3.67 | -256.9% | — | — | — |
| Q4 2023 | 2024-03-12 | -5.50 | -6.75 | +18.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.